Clinical Trials
3 trialsNCT05044871 2025-06-08
BRIGHT
Tongji Hospital
Phase 2 Completed
NCT03427814 2024-10-26
Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer
BeiGene
Phase 2 Completed
NCT03575065 2024-10-26
Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China
BeiGene
Phase 2 Completed